HopeStage
Back to all studies
RecruitingNCT06702488

Comparing medications and thinking changes after surgery in older adults

About this titleRead the official source — NCT06702488
Medication studyAges 60–80EgyptMental health
The study in practice

Understand this study

Who could participate?

Listed age limits: 60 years to 80 years.

Listed locations
Al FayyumSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 21, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
58
Sponsor
Fayoum University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
Egypt
Age range
From 60 Years to 80 Years
Official registry ID
NCT06702488
Official title
Show the full official title

The Efficacy of Dexmedetomidine and Magnesium Sulfate in Cognitive Dysfunction

Recruitment & locations

Currently recruiting

Al Fayyum

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Fayoum University, a university.

Does this study involve medication?

Yes. The study involves medication, including dexmedetomidine.

Who can participate?

Listed age limits: 60 years to 80 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies